26 search results found

  • Cracking Cancer 2.0 - Lightning Talks

    December 7, 2017 | Startup Exchange Video | Duration: 30:6

    Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.

  • Past Deadline: Feb 25, 2020

    Anglo American seeking startups for February visit

    meeting

    Anglo American, a British mining company, is looking for startups in bio technology, rapid access, improved recovery, dry processing, mining legacy, sensor fusion, and EPC disruption.

  • Immunai

    New York, NY
    Immunai is an end-to-end computational immunology company leveraging the power of single-cell biology and AI to decode the Immune System to improve health and accelerate therapeutics.
    Keywords:
    single-cell sequencing, single-cell genomics, machine learning, Artificial Intelligence

  • PathAI

    Boston, MA
    Biotechnology
    The mission at PathAI is to transform, accelerate and improve cancer diagnosis and cancer care by integrating pathology machine learning / artificial intelligence (AI) with traditional pathology methods in both research and clinical labs. By leveraging recent advances in computational processing... More

  • Volta Labs, Inc.

    Cambridge, MA
    Biotechnology
    Volta Labs, Inc. makes programmable fluidic chips for biological automation. We are a transdisciplinary team combining electronics manufacturing, material science, biochemistry and computer science to enable next-generation of automation for genetic engineering. The vision is to bring the... More

  • BioBuilder

    April 25, 2016 | Startup Exchange Video | Duration: 15:21

    Natalie Kuldell, President, Founder, & Executive Director, BioBuilder Educational Foundation

  • Tue, July 16, 2024 | Conference

    2024 MIT Tokyo Life Science Symposium - Startup Exchange Lightning Talks

    Tokyo, Japan

    Startup Lightning Talks presented at the 2024 MIT Tokyo Life Science Symposium.

     

     

  • Kytopen Corporation

    Cambridge, MA
    Biotechnology
    Kytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... More
    Keywords:
    Flowfect(R), Non-Viral, Gene Editing, CRISPR delivery, Continuous Processing, cell therapy, Genome Engineering, CAR T-cells, Engineered TCR T-cells
  • Tue, January 27, 2026 | Conference

    2026 MIT Korea Conference - Startup Exchange Lightning Talks

    Seoul, Korea

    The 2025 MIT Japan Conference will explore future research trends at MIT, highlighting breakthroughs in key areas such as Soft Materials and Mechanics, Biomedical Innovation, and the impact of Generative AI (GAI) on the Work of the Future. Additional sessions will focus on Quantum and Silicon Photonics, Nanotechnology in materials and additive manufacturing, and the latest Machine Learning and AI tools for chemical discovery. Advances in semiconductor technology, hydrogen innovation, and electrochemistry, as well as thermofluidic interfaces, will also be featured.

    Please visit the MIT ILP site for the full agenda.

  • Cellino Biotech, Inc.

    Cambridge, MA
    Biotechnology
    Cellino has built the first platform that enables precise control over iPS cell fate in their natural environment. Their proprietary delivery technology, NanoLaze, delivers synthetic biology tools to control the sequence of genes being turned on and off inside a cell. This offers precise, “digital”... More